Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
15.66
-0.18 (-1.14%)
At close: May 29, 2025, 4:00 PM
15.64
-0.02 (-0.13%)
After-hours: May 29, 2025, 6:19 PM EDT
Mineralys Therapeutics Market Cap
Mineralys Therapeutics has a market cap or net worth of $1.02 billion as of May 29, 2025. Its market cap has increased by 58.99% in one year.
Market Cap
1.02B
Enterprise Value
677.62M
1-Year Change
58.99%
Ranking
Category
Stock Price
$15.66
Market Cap Chart
Since the IPO on February 10, 2023, Mineralys Therapeutics's market cap has increased from $624.91M to $1.02B, an increase of 63.33%. That is a compound annual growth rate of 23.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2025 | 1.02B | 66.59% |
| Dec 31, 2024 | 612.65M | 73.31% |
| Dec 29, 2023 | 353.50M | -43.43% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 646.05B |
| Johnson & Johnson | 367.53B |
| AbbVie | 325.95B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 271.69B |
| Abbott Laboratories | 231.14B |
| Novartis AG | 221.98B |
| AstraZeneca | 219.74B |